Ragnar Linder
Direttore/Membro del Consiglio presso ALZECURE PHARMA AB
Provenienza dei contatti di primo grado di Ragnar Linder
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Electronic Equipment/Instruments | 18 | |
| Public Company | Biotechnology | 11 | |
Amgen AB
 Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden.
1
| Subsidiary | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ragnar Linder tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AEROCRINE AB | Electronic Equipment/Instruments | Corporate Officer/Principal | |
| MEDISTIM ASA | Medical Specialties | Corporate Officer/Principal | |
| C-RAD AB | Medical Specialties | Founder Sales & Marketing | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Founder | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Eurona Medical Ab
 Eurona Medical Ab Hospital/Nursing ManagementHealth Services Part of Gemini Holdings Plc, Eurona Medical Ab operates a medical facility. The CEO of the Swedish company is Eugen Steiner. Eurona Medical was acquired by Gemini Holdings Plc on December 20, 1999 for $5.04 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Chief Tech/Sci/R&D Officer Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
| ALPHAHELIX MOLECULAR DIAGNOSTICS AB | Medical Distributors | Corporate Officer/Principal | |
Arandi Development AB
 Arandi Development AB Pharmaceuticals: MajorHealth Technology Arandi Development AB is a Swedish pharmaceutical manufacturing company. The private company is based in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHROMOGENICS AB | Industrial Specialties | Sales & Marketing | |
SymCel AB
 SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Chairman | |
Moleculink AB
 Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OSSDSIGN AB | Medical Specialties | Sales & Marketing | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Dag Sedin Innovations AB | Corporate Officer/Principal | ||
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| UNIBAP AB | Packaged Software | Director of Finance/CFO | |
| Svartbäckens Måleri Service AB | Corporate Officer/Principal | ||
| Economista Uppsala AB | Director/Board Member | ||
| öregrundspiren AB | Director/Board Member | ||
| Ekonomgruppen I Uppland AB | Director/Board Member | ||
| Ls Kapitalförvaltning AB | Director/Board Member | ||
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member | |
Nolsterby Invest AB
 Nolsterby Invest AB Investment Banks/BrokersFinance Nolsterby Invest AB is a Swedish company that provides securities trading and management services. The private company is based in Uppsala, Sweden. The CEO of the company is Anders Hedlund. | Investment Banks/Brokers | Chairman Chief Executive Officer | |
Rapp AB
 Rapp AB Information Technology ServicesTechnology Services Rapp AB is a healthcare company based in Örebro, Sweden that provides a systematic approach to postoperative care and quality control. Rapp's innovation, developed by Professor Ulrica Nilsson, involves the use of a patient questionnaire to track their recovery progress and provide quality data to healthcare providers. The goal is to increase patient participation, knowledge, and security while reducing the need for unplanned contacts with healthcare providers. Rapp has won the World Innovation Summit for Health award in 2021. The Swedish company was founded in 2015 by Björn Pettersson and Ulrica Nilsson, with Anders Harald Thunberg as the current CEO. | Information Technology Services | Director/Board Member | |
| van Es Consulting AB | Director/Board Member | ||
| Ac Intressenter AB | Chairman Director/Board Member | ||
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Biotechnology | Chairman Director/Board Member | |
| Alzecure Discovery AB | Chairman Chief Executive Officer | ||
| Hepapredict AB | Director/Board Member | ||
| C26 Bioscience AB | Director/Board Member | ||
| Uppsala Universitet Innovation Tools AB | Director/Board Member | ||
| Arandi Holdings AB | Corporate Officer/Principal | ||
| Uppsala Berzelii Technology Centre For Neurodiagnostics | Director/Board Member | ||
| Uppsala University Innovation | Corporate Officer/Principal | ||
Novus Scientific AB
 Novus Scientific AB Medical SpecialtiesHealth Technology Part of Novus Scientific Pte Ltd., Novus Scientific AB is a Swedish soft tissue regeneration company. The company is based in Stockholm, Sweden. Novus Scientific specializes in TIGR® Matrix Surgical Mesh, which is the world's first long-term resorbable surgical mesh. | Medical Specialties | Corporate Officer/Principal | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOZENGE AB | Pharmaceuticals: Major | Chief Executive Officer | |
Oncodia AB
 Oncodia AB Packaged SoftwareTechnology Services Oncodia AB develops regulatory compliant software for mutation analysis in clinical diagnostics. The company is based in Uppsala, Sweden. The Swedish company was founded by Ivaylo Stoimenov. The CEO is Kristofer Maad. | Packaged Software | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 42 |
| Stati Uniti | 7 |
| Paesi Bassi | 3 |
| Norvegia | 2 |
Settori
| Health Technology | 18 |
| Consumer Services | 6 |
| Technology Services | 5 |
| Health Services | 4 |
| Electronic Technology | 3 |
Posizioni
| Director/Board Member | 101 |
| Corporate Officer/Principal | 47 |
| Chief Executive Officer | 44 |
| Chairman | 36 |
| Independent Dir/Board Member | 12 |
Contatti più connessi
- Borsa valori
- Insiders
- Ragnar Linder
- Connessioni Società
